NCT05772156View on ClinicalTrials.gov

Prophylactic Methylergonovine for Twin Cesarean

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

March 3, 2024

Study Completion Date

March 11, 2024

Conditions
Twin; Complicating PregnancyPostpartum Hemorrhage
Interventions
DRUG

Methylergonovine

Methylergonovine 200mcg Intramuscular (IM)

DRUG

Placebo

Matching saline placebo

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER